Department of Burn and Plastic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, and the Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Adv Mater. 2024 Jan;36(2):e2309719. doi: 10.1002/adma.202309719. Epub 2023 Nov 27.
Stem cell-based therapies have exhibited significant promise in the treatment of diabetic ulcers (DU). Nevertheless, enhancing the survival rate and functionality of transplanted stem cells poses a substantial challenge. In this study, inspired by the breadmaking process, yeast microcarriers (YMC) are devised as vehicles for stem cells to address these challenges. The fabrication of YMC involves the amalgamation of microfluidic emulsification with yeast-mediated fermentation, yielding microcarriers with outstanding biocompatibility, high porosity, and antioxidant activity. Adipose-derived stem cells (ADSCs) seeded onto YMC display remarkable cell viability and retain their cellular functions effectively. Additionally, YMC boast a rich glutathione content and exhibit remarkable ROS scavenging ability, thus shielding the ADSCs from oxidative stress. In vivo experiments further substantiate that ADSC@YMC implementation significantly lowered ROS levels in diabetic wounds, resulting in enhanced stem cell retention and improved angiogenesis, collagen deposition, and tissue regeneration. These results highlight the potential of ADSC@YMC as a promising platform for delivering stem cell in the treatment of diabetic wounds.
基于干细胞的疗法在治疗糖尿病溃疡(DU)方面表现出了巨大的潜力。然而,提高移植干细胞的存活率和功能仍然是一个巨大的挑战。在这项研究中,受面包制作过程的启发,我们设计了酵母微载体(YMC)作为干细胞的载体来应对这些挑战。YMC 的制备涉及微流控乳化与酵母介导的发酵相结合,得到的微载体具有出色的生物相容性、高孔隙率和抗氧化活性。接种在 YMC 上的脂肪来源干细胞(ADSCs)表现出显著的细胞活力,并能有效地保持其细胞功能。此外,YMC 富含谷胱甘肽,具有显著的 ROS 清除能力,从而保护 ADSCs 免受氧化应激。体内实验进一步证实,ADSC@YMC 的应用显著降低了糖尿病伤口中的 ROS 水平,从而提高了干细胞的保留率,并改善了血管生成、胶原沉积和组织再生。这些结果突出了 ADSC@YMC 作为一种有前途的递送干细胞治疗糖尿病溃疡的平台的潜力。